In obesity, low-grade chronic inflammation, adipocyte dysfunction and metabolic abnormalities alter the breast tumour microenvironment and upregulate expression of aromatase [14] to exacerbate risk for breast cancer incidence and progression. The gene discussed is CYP19A1; the disease is breast carcinoma.